GSK announces 2009 year-end financial results

GSK delivers 2009 EPS of 121.2p before major restructuring*
and dividend of 61p (+4p)
- Strategy supports return to sales growth (+3%)
- Sustained R&D productivity; with further actions to improve returns

GSK publiziert die Halbjahresresultate 2009

Link zur vollständigen (englischen) Pressemeldung